KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for BioNTech SE (BNTX) over the last 7 years, with Q3 2025 value amounting to 0.05%.

  • BioNTech SE's Return on Capital Employed changed 0.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.06% for FY2024, which is 1000.0% down from last year.
  • According to the latest figures from Q3 2025, BioNTech SE's Return on Capital Employed is 0.05%, which was down 0.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Return on Capital Employed registered a high of 124605.11% during Q1 2021, and its lowest value of 0.07% during Q1 2025.
  • Its 5-year average for Return on Capital Employed is 12064.1%, with a median of 0.27% in 2023.
  • Data for BioNTech SE's Return on Capital Employed shows a peak YoY increase of 1246053800bps (in 2021) and a maximum YoY decrease of -1933160900bps (in 2021) over the last 5 years.
  • BioNTech SE's Return on Capital Employed (Quarter) stood at 0.94% in 2021, then fell by -29bps to 0.66% in 2022, then crashed by -95bps to 0.03% in 2023, then tumbled by -299bps to 0.07% in 2024, then grew by 29bps to 0.05% in 2025.
  • Its Return on Capital Employed was 0.05% in Q3 2025, compared to 0.05% in Q2 2025 and 0.07% in Q1 2025.